Combination of radiation and suicide gene therapy with radio-sensitized promoter/Endotherial precursor cell in glioma
Combination of radiation and suicide gene therapy with radio-sensitized promoter/Endotherial precursor cell in glioma
批准号:
14571350
负责人:
OGA Masaru
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
在第一年,我们证实了位于辐射敏化启动子下游的基因表达确实会被辐射放大。我们构建了含E_4/CMV嵌合放射增敏启动子(E_4:位于Egr-1基因的CArG元件的四重重复结构)的EGFP和HSV-tk载体。将E_4/EGFP基因转染U251-MG/U373-MG细胞,3Gy照射后,荧光显微镜下观察EGFP的表达,Western blotting检测EGFP的表达。结果,我们证实,与照射前阶段相比,在6 × 54小时后,EGFP的表达扩增了约1.3 × 1.4倍。将E4/HSV-tk和HSV-tk分别转染U251-MG/U373-MG胶质瘤细胞系,MTT法检测GCV照射后(1、3、5Gy)细胞增殖情况。结果表明:(1)放射增敏启动子也能被物理或化学刺激激活; 2)E_4/HSV-tk组仅出现辐射剂量依赖性的细胞凋亡,但无统计学意义,第二年我们用<9ns-2>辐射增敏作用强于E_4的E_4替换启动子,进行同样的实验。但与预期相反,在E_ /EGFP -处理组中,EGFP的表达并没有显著增加<9ns-2>。MTT法也未证实E_<9ns-2>/HSV-tk对胶质瘤细胞株的增殖有明显抑制作用。本研究拟以E_4/CMV为放射增敏启动子,将E_4/HSV-tk基因导入C6和内皮前体细胞系,进一步推进我们的研究计划。
英文摘要
In the first year we verified that the gene expression located at the downstream of radio-sensitized promoter would actually amplify by radiation. We constructed the EGFP&HSV-tk vectors containing E_4/CMV chimeric radio-sensitized promoter (E_4: four-repeated structure of CArG element located at Egr-1 gene). E_4/EGFP was transferred into U251-MG/U373-MG human glioma cell line respectively and the expression of EGFP was evaluated by optical observation under fluorescent microscopy and Western blotting after 3Gy irradiation. As a result, we verified that the expression of EGFP was amplified about 1.3〜1.4 times after 6〜54 hours compared to pre-irradiation stage. Then E4/HSV-tk and HSV-tk were transferred into U251-MG/U373-MG human glioma cell line respectively, and the degree of cell proliferation was evaluated by MTT assay after irradiation (1,3,5Gy) following GCV administration. The results were 1)the radio-sensitized promoter also could be activated by physical/chemical stimuli. 2)the radiation dose-dependent apoptosis was observed only in the E_4/HSV-tk-administrative group but not statistically significant.In the second year, we replaced the promoter with E_<9ns-2>, stronger than E_4 in radio-sensitization and did the same trial. Contrary to the expectation, however, the expression of EGFP was not significantly amplified in the E_<9ns-2>/EGFP -administrative groups. In the MTT assay, we also could not verified the significant inhibition of the cell proliferation among E_<9ns-2>/HSV-tk-administrative glioma cell lines after irradiation. We are going to promote our previously scheduled plan by using E_4/CMV as the radio-sensitized promoter, transferring E_4/HSV-tk into C6 and endothelial precursor cell line.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Egr-1通过DMT1激活NCOA4/FTH1通路诱导铁自噬促进铁死亡在阿尔茨海默病中的作用及分子机制
-
批准号:82560270
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:黄忠仕
-
依托单位:
五行音乐羽调对恐惧模型小鼠5-HT/EGR-1/ChAT及“杏仁核”谷氨酸毒性变化的研究
-
批准号:82374556
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李丽
-
依托单位:
p38 MAPK/Elk-1/Egr-1信号轴介导ASM激活所致的细胞泛凋亡PANoptosis在随意皮瓣缺血坏死中的作用及机制研究
-
批准号:82372540
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:周凯亮
-
依托单位:
运用干细胞(类器官)青光眼模型研究Egr-1/c-Fos轴在视神经损伤与修复中的机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:唐明君
-
依托单位:
毛蕊异黄酮激活Egr-1信号途径促Treg极化治疗多发性硬化症的作用机制研究
-
批准号:82104425
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:杨柳
-
依托单位:
Egr-1在铜绿假单胞菌感染时通过促进自体吞噬抑制巨噬细胞吞噬作用的分子机制研究
-
批准号:82002112
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:庞政
-
依托单位:
长期锻炼作用下早期生长因子Egr-1介导骨骼肌细胞糖脂代谢模式变化及分泌以调控脂肪细胞脂质积累的机制研究
-
批准号:91857109
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2018
-
负责人:李朝军
-
依托单位:
iPSC来源外泌体miRNAs靶向调控Egr-1/Agrin通路抑制增龄性心房重构和心房颤动作用机制研究
-
批准号:81870257
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:郑强荪
-
依托单位:
A2aR/Egr-1/Pdx-1信号介导咖啡因所致的胎胰腺发育异常
-
批准号:81703631
-
项目类别:青年科学基金项目
-
资助金额:20.8万元
-
批准年份:2017
-
负责人:寇皓
-
依托单位:
突变p53通过Egr-1/p300介导电离辐射激活Cathepsin L的机制
-
批准号:81773768
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2017
-
负责人:梁中琴
-
依托单位: